SoftBank Group to Form Joint Venture With U.S. Healthcare Firm Tempus AI
By Megumi Fujikawa
TOKYO--SoftBank Group will introduce a medical service backed by artificial intelligence in Japan via its new joint venture with U.S. healthcare firm Tempus AI.
The new company will analyze patients' data, such as genetic information and other medical records, using Tempus's artificial intelligence and offer doctors options for treatments, SoftBank said.
"It is definitely beneficial to reduce people's sadness," SoftBank Group Chief Executive Masayoshi Son said at a news conference Thursday. Son said he wanted to start offering the service in Japan by the end of this year.
The joint venture will be capitalized at 30 billion yen, equivalent to $187 million. SoftBank and Tempus will each own a 50% stake.
Chicago-based Tempus went public on the Nasdaq market earlier this month, with a market capitalization of over $4 billion as of Wednesday's close.
This was Son's first major AI announcement after he said at an annual shareholder meeting last week that the company aims to realize artificial super intelligence, which he said would be 10,000 times smarter than human intelligence.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
(END) Dow Jones Newswires
June 27, 2024 04:56 ET (08:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
Markets Brief: US Jobs Report In View as Q3 Begins
-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Energy: OPEC Continues to Operate From a Position of Weakness With Production Cuts Extension
-
Communication Services: Online Advertising Remains Strong, but Growth Will Likely Decelerate
-
3 Stocks to Buy This Summer While They’re Seriously Undervalued
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded